What is AMREP Corporation's earnings per share (EPS)?

AMREP Corporation (AXR) reported diluted earnings per share of $1.91 for fiscal year 2026. This represents a -19.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

AMREP Corporation (AXR) Financials

AXR

Trailing 12 months to July 31, 2026

Revenue $41.0M -15.3% YoY

Net Income $6.0M -55.3% YoY

EPS (Diluted) $1.08 -56.5% YoY

Free Cash Flow -$367K -104.3% YoY

Market Cap $108.2M as of Oct 21, 2026

Price / Sales 2.6x on $41.0M revenue, trailing 12 months to July 31, 2026

Price / Earnings 18.1x on $6.0M net income, trailing 12 months to July 31, 2026

Price / Book 0.8x on $141.1M equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 21, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jul 31, 2026 Reported Sep 11, 2026 Currency USD FYE April

Newest figures come from the 10-Q for Q1 FY2027, filed Sep 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AXR SEC filings page.

AMREP Corporation (AXR) reported $41.0M in revenue over the twelve months to Jul 31, 2026, down 15.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AXR FY2026 2026-10-04

AMREP converts reported earnings into cash with little reinvestment or debt, while rising overhead limits how much revenue reaches profit.

FY2026 revenue recovered from the prior year, but operating margin narrowed, showing that additional sales did not translate proportionally into operating earnings. Higher overhead coincided with net income falling to $10.4M even as revenue reached $52.8M, pointing to cost pressure rather than a volume problem alone.

FY2026 operating cash flow was $12.9M versus free cash flow of $12.8M; that tight spread means cash conversion remained high because capital spending absorbed little operating cash.

Total assets reached $144.9M while liabilities were only $4.1M. The balance sheet is equity-funded: equity reached $140.7M and debt-to-equity was just 0.0001x, leaving reported operations largely independent of borrowing.

Financial Health Signals

Financial Health Score 50/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of AMREP Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

AMREP Corporation has an operating margin of 23.4%, meaning the company retains $23 of operating profit per $100 of revenue. This strong profitability earns a score of 80/100, reflecting efficient cost management and pricing power. This is down from 24.4% the prior year.

Growth

AMREP Corporation's revenue grew 6.3% year-over-year to $52.8M, a solid pace of expansion. This earns a growth score of 35/100.

Leverage

AMREP Corporation carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Not available for AMREP Corporation, and counted as zero in the overall score.

Cash Flow

AMREP Corporation converts 24.2% of revenue into free cash flow ($12.8M). This strong cash generation earns a score of 88/100.

Returns

Not available for AMREP Corporation, and counted as zero in the overall score.

Piotroski F-Score Partial

4/7

AMREP Corporation passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.24x

For every $1 of reported earnings, AMREP Corporation generates $1.24 in operating cash flow ($12.9M OCF vs $10.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

7.15x

AMREP Corporation earns $7.15 in operating income for every $1 of interest expense ($12.4M vs $1.7M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.1M

YoY-66.1%

QoQ-45.1%

5Y CAGR-10.4%

AMREP Corporation generated $6.1M in revenue in Q1 2027. This represents a decrease of 66.1% from the same quarter a year earlier. Against the prior quarter it is down 45.1%.

EBITDA

-$85K

YoY-101.4%

QoQ-103.9%

AMREP Corporation's EBITDA was -$85K in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 101.4% from the same quarter a year earlier. Against the prior quarter it is down 103.9%.

Net Income

$276K

YoY-94.1%

QoQ-79.5%

5Y CAGR-30.0%

AMREP Corporation reported $276K in net income in Q1 2027. This represents a decrease of 94.1% from the same quarter a year earlier. Against the prior quarter it is down 79.5%.

EPS (Diluted)

$0.05

YoY-94.3%

QoQ-78.3%

5Y CAGR-25.6%

AMREP Corporation earned $0.05 per diluted share (EPS) in Q1 2027. This represents a decrease of 94.3% from the same quarter a year earlier. Against the prior quarter it is down 78.3%.

Cash & Balance Sheet

Free Cash Flow

-$3.6M

YoY-138.3%

QoQ-265.5%

AMREP Corporation recorded an outflow of $3.6M in free cash flow in Q1 2027, representing a cash shortfall after capex. This represents a decrease of 138.3% from the same quarter a year earlier. Against the prior quarter it is down 265.5%.

Cash & Debt

$48.7M

YoY-0.5%

QoQ-7.0%

5Y CAGR+15.9%

10Y CAGR+15.7%

AMREP Corporation held $48.7M in cash against $17K in long-term debt as of Q1 2027.

Shares Outstanding

YoY+0.4%

QoQ0.0%

AMREP Corporation had 5M shares outstanding in Q1 2027. This represents an increase of 0.4% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Operating Margin

-2.7%

YoY-37.1pp

QoQ-21.9pp

5Y change-19.8pp

AMREP Corporation's operating margin was -2.7% in Q1 2027, reflecting core business profitability. This is down 37.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 21.9 percentage points.

Net Margin

4.6%

YoY-21.7pp

QoQ-7.7pp

5Y change-11.0pp

AMREP Corporation's net profit margin was 4.6% in Q1 2027, showing the share of revenue converted to profit. This is down 21.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 7.7 percentage points.

Return on Equity

0.2%

YoY-3.3pp

QoQ-0.8pp

5Y change-1.6pp

AMREP Corporation's ROE was 0.2% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 3.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Gross Margin

Not reported for Q1 2027.

Capital Allocation

Capital Expenditures

$4K

YoY-80.0%

QoQ+33.3%

5Y CAGR+32.0%

10Y CAGR-20.4%

AMREP Corporation invested $4K in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 80.0% from the same quarter a year earlier. Against the prior quarter it is up 33.3%.

R&D Spending

Not reported for Q1 2027.

Share Buybacks

Not reported for Q1 2027.

AXR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AXR quarterly income statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$41.0M	$52.8M+6.3%	$49.7M-3.3%	$51.4M+5.5%	$48.7M-17.4%	$58.9M+47.1%	$40.1M+113.3%	$18.8M+46.4%	$12.8M+43.7%	$8.9M-78.9%	$42.4M+1.7%	$41.7M-16.3%	$49.8M-19.9%	$62.2M-25.1%	$83.0M-2.8%	$85.4M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$13.3M+23.5%	$10.8M+77.8%	$6.1M	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$5.5M+166.3%	$2.1M-28.3%	$2.9M	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$9.6M	$9.0M+24.0%	$7.3M+5.9%	$6.9M+25.6%	$5.5M+2.2%	$5.4M-1.2%	$5.4M-58.2%	$13.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	$6.1M	$12.4M+2.4%	$12.1M+59.3%	$7.6M+30.4%	$5.8M-72.6%	$21.3M+135.5%	$9.0M+213.7%	-$8.0M-146.8%	-$3.2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA	N/A	$12.7M+3.4%	$12.3M+58.5%	$7.8M+31.5%	$5.9M-72.6%	$21.5M+124.2%	$9.6M+229.4%	-$7.4M-183.4%	-$2.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	$1.7M+6.9%	$1.6M+97.1%	$823K+10187.5%	$8K+300.0%	$2K+105.0%	-$40K-112.0%	$334K+1236.0%	$25K+400.0%	$5K-98.5%	$333K-75.5%	$1.4M-15.7%	$1.6M-6.2%	$1.7M+13.9%	$1.5M+7.7%	$1.4M
Income Tax	$1.9M	$3.8M+280.4%	$1.0M-41.8%	$1.7M+112.3%	-$14.1M-348.1%	$5.7M+115.8%	$2.6M+253.5%	-$1.7M-143.2%	-$708K-153.8%	-$279K-128.0%	$997K+119.1%	-$5.2M-144.4%	-$2.1M-276.0%	-$567K+67.8%	-$1.8M-96.3%	-$896K
Net Income	$6.0M	$10.4M-18.3%	$12.7M+90.1%	$6.7M-69.3%	$21.8M+37.4%	$15.9M+114.6%	$7.4M+225.2%	-$5.9M-486.6%	$1.5M+541.6%	$238K+1686.7%	-$15K+99.9%	-$10.2M-190.3%	$11.3M+485.2%	-$2.9M-3.6%	-$2.8M-148.3%	-$1.1M
EPS (Basic)	N/A	$1.93-19.2%	$2.39+89.7%	$1.26-69.5%	$4.13+86.9%	$2.21+132.6%	$0.95+230.1%	-$0.73	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	$1.08	$1.91-19.4%	$2.37+89.6%	$1.25-69.6%	$4.11+86.0%	$2.21+132.6%	$0.95+230.1%	-$0.73	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	5M+0.4%	5M+0.4%	5M+100653.7%	5,307-26.2%	7,193-7.5%	7,773-4.4%	8,134-0.1%	8,145+0.5%	8,104-99.9%	8M+0.2%	8M	N/A	N/A	N/A	N/A

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Revenue	$6.1M-66.1%	$11.0M-1.4%	$14.6M+93.8%	$9.4M-21.1%	$17.9M-6.5%	$11.2M-42.8%	$7.5M-40.7%	$11.9M+34.5%
SG&A Expenses	$2.4M+30.4%	$2.3M+17.7%	$2.9M+56.3%	$2.0M+7.2%	$1.8M+13.2%	$1.9M+5.3%	$1.9M-1.4%	$1.8M+18.0%
Operating Income	-$163K-102.7%	$2.1M-40.1%	$3.0M+596.1%	$1.1M-64.4%	$6.1M+23.1%	$3.5M-24.3%	$432K+391.9%	$3.1M+199.1%
EBITDA	-$85K-101.4%	$2.2M-39.2%	$3.1M+564.6%	$1.2M-62.4%	$6.2M+23.5%	$3.6M-24.0%	$466K+498.3%	$3.2M+191.5%
Interest Expense	N/A	$426K+20.0%	$393K-4.1%	$459K-20.3%	$456K+62.3%	$355K+1.4%	$410K+56.5%	$576K+253.4%
Income Tax	$9K-99.5%	$1.3M+43333.3%	$253K+102.4%	$378K+217.4%	$1.9M+58.0%	-$3K-100.3%	$125K+468.2%	-$322K-403.8%
Net Income	$276K-94.1%	$1.3M-65.4%	$3.1M+338.9%	$1.2M-70.3%	$4.7M+15.5%	$3.9M-6.1%	$717K+679.3%	$4.0M+264.8%
EPS (Basic)	$0.05-94.3%	$0.24-67.1%	$0.59+353.8%	$0.22-71.1%	$0.88+14.3%	$0.73-6.4%	$0.13+550.0%	$0.76+261.9%
EPS (Diluted)	$0.05-94.3%	$0.23-68.5%	$0.58+346.2%	$0.22-70.7%	$0.87+14.5%	$0.73-5.2%	$0.13+550.0%	$0.75+257.1%
Diluted Shares (Avg)	5M+0.3%	N/A	5M+0.1%	5M+0.3%	5M+0.4%	N/A	5M+0.7%	5M+0.7%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

AXR Balance Sheet

AXR quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$144.9M+8.3%	$133.8M+8.9%	$122.8M+6.0%	$115.9M+22.1%	$94.9M-2.5%	$97.4M+0.7%	$96.7M-3.8%	$100.5M-5.4%	$106.2M-0.4%	$106.7M-11.6%	$120.6M-13.0%	$138.7M-25.5%	$186.1M-5.0%	$195.9M-3.5%	$203.0M
Cash & Equivalents	$52.3M+32.6%	$39.5M+32.9%	$29.7M+48.5%	$20.0M+27.2%	$15.7M-36.6%	$24.8M+41.7%	$17.5M+31.9%	$13.3M+22.3%	$10.9M-8.1%	$11.8M-18.9%	$14.6M+20.8%	$12.1M+59.2%	$7.6M+194.9%	$2.6M-90.8%	$27.8M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	$5.9M-7.5%	$6.4M-12.3%	$7.3M-35.5%	$11.3M+2.8%	$11.0M-76.8%	$47.3M+16.5%	$40.6M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$609K	$0	$0	$0	$0
Total Liabilities	$4.1M+8.5%	$3.8M-20.2%	$4.8M-2.3%	$4.9M-58.4%	$11.8M+38.7%	$8.5M-29.5%	$12.0M+12.6%	$10.7M-44.0%	$19.1M-12.6%	$21.8M-42.2%	$37.8M-16.8%	$45.4M-57.5%	$106.8M-13.4%	$123.3M-4.0%	$128.4M
Long-Term Debt	$18K-30.8%	$26K-25.7%	$35K-20.5%	$44K-97.8%	$2.0M-41.7%	$3.5M-9.6%	$3.9M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$140.7M+8.3%	$130.0M+10.1%	$118.0M+6.4%	$111.0M+33.5%	$83.2M-6.4%	$88.9M+5.0%	$84.6M-5.8%	$89.8M+3.1%	$87.1M+2.1%	$85.4M+3.0%	$82.8M-11.2%	$93.3M+17.7%	$79.3M+9.3%	$72.5M-2.8%	$74.6M
Retained Earnings	$106.3M+10.7%	$96.0M+15.3%	$83.3M+8.7%	$76.6M+39.7%	$54.8M+14.9%	$47.7M+10.6%	$43.1M-12.0%	$49.1M+3.2%	$47.5M+0.5%	$47.3M+1.1%	$46.8M-17.9%	$57.0M+24.8%	$45.7M-28.5%	$63.9M-4.3%	$66.8M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Total Assets	$145.7M+3.6%	$144.9M+8.3%	$143.9M+11.6%	$140.1M+8.6%	$140.7M+10.8%	$133.8M+8.9%	$128.9M+8.4%	$129.1M+9.6%
Cash & Equivalents	$48.7M-0.5%	$52.3M+32.6%	$50.0M+35.4%	$44.6M+11.3%	$48.9M+21.3%	$39.5M+32.9%	$36.9M+105.1%	$40.1M+139.7%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0-100.0%	$0-100.0%
Accounts Receivable	N/A	$0	$0	N/A	$0	$0	$0	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$4.5M-23.4%	$4.1M+8.5%	$4.6M+54.1%	$4.1M+2.5%	$5.9M+22.7%	$3.8M-20.2%	$3.0M-43.1%	$4.0M-5.0%
Long-Term Debt	$17K-32.0%	$18K-30.8%	$21K-27.6%	$23K-28.1%	$25K-26.5%	$26K-25.7%	$29K-21.6%	$32K-17.9%
Total Equity	$141.1M+4.7%	$140.7M+8.3%	$139.4M+10.6%	$136.0M+8.8%	$134.7M+10.3%	$130.0M+10.1%	$126.0M+10.7%	$125.1M+10.2%
Retained Earnings	$106.6M+5.8%	$106.3M+10.7%	$105.1M+14.0%	$101.9M+11.5%	$100.7M+15.3%	$96.0M+15.3%	$92.1M+16.4%	$91.4M+15.6%

Not reported in any period shown, so not listed: Current Assets, Inventory, Goodwill, Current Liabilities, Non-Current Liabilities.

AXR Cash Flow Statement

AXR quarterly cash flow statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	-$281K	$12.9M+25.7%	$10.2M-4.4%	$10.7M+67.7%	$6.4M-58.7%	$15.5M+22.7%	$12.6M+1548.2%	$765K+29.2%	$592K+11.5%	$531K-94.9%	$10.4M+201.0%	$3.5M-65.2%	$10.0M+81.3%	$5.5M+147.3%	-$11.6M-299.8%	$5.8M
Depreciation & Amortization	N/A	$312K+74.3%	$179K+20.1%	$149K+136.5%	$63K-72.0%	$225K-59.4%	$554K+3.2%	$537K-11.4%	$606K-51.4%	$1.2M-10.7%	$1.4M-53.1%	$3.0M-8.8%	$3.3M+2.3%	$3.2M-15.2%	$3.8M-24.4%	$5.0M
Stock-Based Compensation	N/A	$447K+5.7%	$423K+33.4%	$317K+33.2%	$238K+9.7%	$217K+64.4%	$132K+16.8%	$113K-51.1%	$231K+30.5%	$177K+51.3%	$117K+72.1%	$68K-44.3%	$122K+159.6%	$47K	$0	$0
Capital Expenditures	$86K	$102K-82.5%	$583K+27.6%	$457K+248.9%	$131K-89.8%	$1.3M+25640.0%	$5K-44.4%	$9K+12.5%	$8K-84.6%	$52K-79.1%	$249K-68.8%	$798K-29.2%	$1.1M-10.5%	$1.3M+20.0%	$1.0M-2.2%	$1.1M
Free Cash Flow	-$367K	$12.8M+32.3%	$9.7M-5.8%	$10.3M+63.9%	$6.3M-55.9%	$14.2M+12.6%	$12.6M+1567.2%	$756K+29.5%	$584K+21.9%	$479K-95.3%	$10.2M+281.7%	$2.7M-69.8%	$8.8M+108.6%	$4.2M+133.5%	-$12.7M-367.2%	$4.7M
Investing Cash Flow	-$86K	-$102K+81.6%	-$553K-21.0%	-$457K-248.9%	-$131K+89.0%	-$1.2M-23800.0%	-$5K+44.4%	-$9K-105.9%	$152K+209.4%	-$139K+44.2%	-$249K-108.9%	$2.8M+348.6%	-$1.1M+10.5%	-$1.3M+42.0%	-$2.2M-104.7%	-$1.1M
Financing Cash Flow	-$7K	-$8K+11.1%	-$9K0.0%	-$9K+99.5%	-$2.0M+91.5%	-$23.4M-340.4%	-$5.3M-311.4%	$2.5M+557.2%	-$549K-129.9%	$1.8M+114.2%	-$12.9M-244.4%	-$3.8M+13.8%	-$4.4M-667.2%	$768K+321.3%	-$347K+87.0%	-$2.7M
Share Buybacks	N/A	N/A	N/A	N/A	$0-100.0%	$21.9M+328.1%	$5.1M	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Cash Flow	-$3.6M-138.2%	$2.2M-25.9%	$5.4M+267.0%	-$4.3M-2236.3%	$9.5M-10.9%	$3.0M-59.5%	-$3.2M-313.7%	-$182K-555.0%
Depreciation & Amortization	$78K0.0%	$62K+26.5%	$90K+164.7%	$82K+70.8%	$78K+62.5%	$49K+16.7%	$34K+9.7%	$48K+9.1%
Stock-Based Compensation	$121K+21.0%	N/A	N/A	N/A	$100K+12.4%	N/A	N/A	N/A
Capital Expenditures	$4K-80.0%	$3K-99.3%	$19K-26.9%	$60K-30.2%	$20K-41.2%	$437K+199.3%	$26K-85.2%	$86K-9.5%
Free Cash Flow	-$3.6M-138.3%	$2.2M-13.2%	$5.4M+265.1%	-$4.3M-1509.0%	$9.5M-10.8%	$2.5M-64.8%	-$3.3M-343.8%	-$268K-387.3%
Investing Cash Flow	-$4K+80.0%	-$3K+99.3%	-$19K-575.0%	-$60K+30.2%	-$20K+41.2%	-$437K-108.9%	$4K+101.8%	-$86K+98.3%
Financing Cash Flow	-$1K+50.0%	-$3K-50.0%	-$2K+50.0%	-$1K+50.0%	-$2K-100.0%	-$2K0.0%	-$4K-100.0%	-$2K0.0%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

AXR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AXR quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	29.1%+13.1pp	16.0%-16.1pp	32.1%	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	23.4%-0.9pp	24.4%+9.6pp	14.8%+2.8pp	12.0%-24.2pp	36.1%+13.6pp	22.6%+65.0pp	-42.4%-17.2pp	-25.1%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	19.7%-5.9pp	25.6%+12.6pp	13.0%-31.8pp	44.8%+17.8pp	26.9%+8.5pp	18.4%+49.9pp	-31.4%-43.3pp	11.9%+9.2pp	2.7%+2.7pp	0.0%+24.5pp	-24.5%-47.3pp	22.7%+27.5pp	-4.7%-1.3pp	-3.4%-2.1pp	-1.3%
Return on Equity	7.4%-2.4pp	9.8%+4.1pp	5.7%-14.0pp	19.6%+0.6pp	19.1%+10.8pp	8.3%+15.3pp	-7.0%-8.7pp	1.7%+1.4pp	0.3%+0.3pp	0.0%+12.3pp	-12.3%-24.5pp	12.1%+15.8pp	-3.7%+0.2pp	-3.9%-2.4pp	-1.5%
Return on Assets	7.2%-2.3pp	9.5%+4.1pp	5.5%-13.4pp	18.8%+2.1pp	16.7%+9.1pp	7.6%+13.7pp	-6.1%-7.6pp	1.5%+1.3pp	0.2%+0.2pp	0.0%+8.5pp	-8.5%-16.6pp	8.2%+9.7pp	-1.6%-0.1pp	-1.5%-0.9pp	-0.6%
Debt-to-Equity	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.020.0x	0.040.0x	0.05-0.1x	0.12-0.1x	0.220.0x	0.26-0.2x	0.460.0x	0.49-0.9x	1.35-0.4x	1.700.0x	1.72
Asset Turnover	0.360.0x	0.370.0x	0.420.0x	0.42-0.2x	0.62+0.2x	0.41+0.2x	0.19+0.1x	0.130.0x	0.08-0.3x	0.40+0.1x	0.350.0x	0.360.0x	0.33-0.1x	0.420.0x	0.42
FCF Margin	24.2%+4.7pp	19.4%-0.5pp	20.0%+7.1pp	12.9%-11.2pp	24.1%-7.4pp	31.5%+27.4pp	4.0%-0.5pp	4.5%-0.8pp	5.4%-18.7pp	24.1%+17.6pp	6.4%-11.3pp	17.7%+10.9pp	6.8%+22.1pp	-15.3%-20.8pp	5.5%

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Margin	-2.7%-37.1pp	19.2%-12.4pp	20.6%+14.9pp	11.9%-14.5pp	34.4%+8.3pp	31.7%+7.7pp	5.7%+6.9pp	26.4%+14.5pp
Net Margin	4.6%-21.7pp	12.2%-22.6pp	21.6%+12.1pp	12.8%-21.2pp	26.3%+5.0pp	34.8%+13.6pp	9.5%+8.8pp	34.0%+21.4pp
Return on Equity	0.2%-3.3pp	1.0%-2.0pp	2.3%+1.7pp	0.9%-2.4pp	3.5%+0.1pp	3.0%-0.5pp	0.6%+0.5pp	3.2%+2.3pp
Return on Assets	0.2%-3.1pp	0.9%-2.0pp	2.2%+1.6pp	0.9%-2.3pp	3.3%+0.1pp	2.9%-0.5pp	0.6%+0.5pp	3.1%+2.2pp
Debt-to-Equity	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x
Asset Turnover	0.04-0.1x	0.080.0x	0.100.0x	0.070.0x	0.130.0x	0.08-0.1x	0.060.0x	0.090.0x
FCF Margin	-60.1%-113.4pp	19.9%-2.7pp	37.0%+80.3pp	-45.9%-43.6pp	53.3%-2.6pp	22.7%-14.1pp	-43.4%-53.9pp	-2.3%-1.6pp

Not reported in any period shown, so not listed: Gross Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
AMREP Corporation AXR	FY2026	$52.8M	$10.4M	19.7%	$108.2M	50/100
Alset Inc. AEI	FY2025	$4.5M	-$47.4M	N/A	$22.5M	28/100
Logistic Properties of the Americas LPA	FY2025	$50.1M	$16.1M	32.1%	$87.5M	31/100
JFB Construction Holdings JFB	FY2025	$30.5M	-$5.3M	-17.3%	$100.0M	55/100
Belpointe PREP, LLC OZ	FY2025	$9.2M	-$40.0M	N/A	$146.9M	24/100

Where AMREP Corporation Ranks

Frequently Asked Questions

What is AMREP Corporation's annual revenue?

AMREP Corporation (AXR) reported $52.8M in total revenue for fiscal year 2026. This represents a 6.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is AMREP Corporation's revenue growing?

AMREP Corporation (AXR) revenue grew by 6.3% year-over-year, from $49.7M to $52.8M in fiscal year 2026.

Is AMREP Corporation profitable?

Yes, AMREP Corporation (AXR) reported a net income of $10.4M in fiscal year 2026, with a net profit margin of 19.7%.

What is AMREP Corporation's EBITDA?

AMREP Corporation (AXR) had EBITDA of $12.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does AMREP Corporation have?

As of fiscal year 2026, AMREP Corporation (AXR) had $52.3M in cash and equivalents against $18K in long-term debt.

What is AMREP Corporation's operating margin?

AMREP Corporation (AXR) had an operating margin of 23.4% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is AMREP Corporation's net profit margin?

AMREP Corporation (AXR) had a net profit margin of 19.7% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is AMREP Corporation's return on equity (ROE)?

AMREP Corporation (AXR) has a return on equity of 7.4% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is AMREP Corporation's free cash flow?

AMREP Corporation (AXR) generated $12.8M in free cash flow during fiscal year 2026. This represents a 32.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is AMREP Corporation's operating cash flow?

AMREP Corporation (AXR) generated $12.9M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are AMREP Corporation's total assets?

AMREP Corporation (AXR) had $144.9M in total assets as of fiscal year 2026, including both current and long-term assets.

What are AMREP Corporation's capital expenditures?

AMREP Corporation (AXR) invested $102K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How many shares does AMREP Corporation have outstanding?

AMREP Corporation (AXR) had 5M shares outstanding as of fiscal year 2026.

What is AMREP Corporation's debt-to-equity ratio?

AMREP Corporation (AXR) had a debt-to-equity ratio of 0.00 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is AMREP Corporation's return on assets (ROA)?

AMREP Corporation (AXR) had a return on assets of 7.2% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is AMREP Corporation's P/E ratio?

AMREP Corporation (AXR) trades at 18.1x earnings, its market capitalization divided by net income of $6.0M net income, trailing 12 months to July 31, 2026. The market capitalization is $108.2M as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is AMREP Corporation's price-to-sales ratio?

AMREP Corporation (AXR) trades at 2.6x sales, its market capitalization divided by revenue of $41.0M revenue, trailing 12 months to July 31, 2026. The market capitalization is $108.2M as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is AMREP Corporation's Piotroski F-Score?

AMREP Corporation (AXR) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are AMREP Corporation's earnings high quality?

AMREP Corporation (AXR) has an earnings quality ratio of 1.24x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can AMREP Corporation cover its interest payments?

AMREP Corporation (AXR) has an interest coverage ratio of 7.15x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is AMREP Corporation?

AMREP Corporation (AXR) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.